Remoscope · Investor Overview
- Early-stage medtech emerging from Biohub
- AI-powered label-free cell morphology platform
- Leveraging years of internal development
- Peer-reviewed clinical malaria validation
- Sepsis: 90-99% AUC in minutes from whole blood
- CNS cell counts validation performed
- De-risked, field-hardened prototype design
- Strong IP position: existing granted and new pending
- Seed round · $6M ($5M venture + $1M non-dilutive) · 24-month runway
- RUO launch + LMIC clinical studies
- Phased development pipeline for regulatory
Masafu General Hospital, Eastern Uganda · 30 April 2026
A child presents with a dangerous fever.
The clinician assumes malaria and orders a test.
The technician is busy.
The family waits for hours.
They give up and go home.
The world's most preventable deaths
happen without a diagnosis
- Rapid tests — single disease, low sensitivity, antigen resistance
- Manual blood smears — skill & labor intensive
- Absence of correct test — resort to non-specific symptoms
Remoscope - Hours to days turnaround
- Cold chain & reagents required
- Inaccessible in most LMICs
Cellular fluid analysis requires
labor-intensive and skill-dependent workflows.
Across CRO, pharma, diagnostics, and clinical settings — the same bottleneck holds: sample prep, staining, manual microscopy, and specialist expertise.
Remoscope
An AI-powered
rapid diagnostic platform
Your cells embedded, in real time.
with low COGS
Same hardware. Many samples.
Label-free · no reagents · edge compute
Unprocessed whole blood
One platform.
Many tasks.
Malaria Diagnosis
Proven in the Field
Rings
Trophozoites
Schizonts
Clinical performance data · Tororo, Uganda
Sepsis kills.
Speed is everything.
Am J Physiol Regul Integr Comp Physiol 324: R613–R624, 2023.
Sepsis Diagnosis · Whole Blood · Minutes
Rule-out: 91.3% sensitivity · 97.0% specificity vs. all · UCSF EARLI cohort · sepsis.realtimeimagingsystems.com
Cell morphology fingerprints
Preliminary sickle cell map with small dataset
- Record blood cell morphology maps for each participant
- Apply a Kleihauer–Betke acid elution assay to lyse HbA cells
- Run acid-eluted samples on Remoscope and quantify F-cell fraction
- Quantify reticulocyte fractions and (stretch goal) HbF content per cell
- Use the resulting data to train combined SCD + malaria remo-Map and remo-ID models
Cellular Liquid Biopsy
for CNS Disease
| Clinical Result | Remoscope Result |
|---|---|
| 13 WBC/µL | 15 WBC/µL |
| 0 WBC/µL | 0 WBC/µL |
| 1 WBC/µL | 1 WBC/µL |
| 7 WBC/µL | 7 WBC/µL |
| 1 WBC/µL | 2.5 WBC/µL |
| 5 WBC/µL | 4.5 WBC/µL |
In collaboration with Dr. Greer Waldrop
UCSF · Department of Neurology
White blood cells in a patient with neurological disease, imaged on Remoscope
Add a sample type.
Ship a software update.
Whole Blood
Malaria · Sepsis · CBC · Sickle Cell
P. falciparum
Sepsis
Sickle cell
CSF
WBC counting · gold standard match
Cerebrospinal fluid
Urine
Cellular analysis · small animal studies
Coming soon
BAL & Other Fluids
Bronchoalveolar · peritoneal · differentials
Coming soon
Two parallel tracks to
revenue and regulatory readiness
RUO Fast-Track Launch
Immediate RUO product launch · early revenue
Product Definition
- RUO-ready instrument specs finalized
- Pricing strategy & go-to-market plan
Commercial Launch
- CRO & pharma partnerships
- First instruments shipped
- Flow cell scale-up: 4K → 20K/yr
Revenue & Diagnostic Expansion
- Early revenue · de-risk platform claims
- Expand assay library
Phased Development Pipeline
Manufacturable device · LMIC validation · WHO prequalification
Product Definition & DFM
- ISO 13485 partner
- Design controls & risk management
Alpha & Beta Systems
- Performance optimization
- Closed-loop AI model expansion
- Neonatal sepsis · 5-part WBC diff
Prospective LMIC Studies
- Tanzania & Uganda deployment
- WHO prequalification filing
- Distribution partnerships
Product Timeline
Key Results to Achieve
with Seed Financing
Raising seed round after leveraging years of internal development at the Biohub.
Published clinical results · Field-hardened prototype · expanding indications · ISO 13485 started · Strong pharma and CRO interest
- Engineering: Alpha system build-out & DFM
- Clinical: LMIC prospective studies ($1M non-dilutive)
- Business: RUO commercialization
- 24 months runway to Series A in no-sales scenario
10+ years building
this specific technology
Paul Lebel
PhD Applied Physics · Stanford · 751 citations · 7 patents
Ilakkiyan Jeyakumar
BASc Engineering Physics · UBC · edge compute · real-time systems
Nicholas Bratvold
BASc Engineering Physics · UBC · remo-ID · remo-DB architect
Rafael Gómez-Sjöberg · Michelle Khoo · Gregory Suematsu · Chris Charlton
UCSF · UC Berkeley · IDRC Uganda · CDC/KEMRI Kenya · Biohub · Pharma
Prof. Joe DeRisi · Dr. Chaz Langelier · Dr. Teresa Kortz · Dr. Greer Waldrop · Prof. Grant Dorsey · Prof. Philip Rosenthal
Attention on
infected red blood cells
High attention areas correlate with clinically-validated malaria detection model1 · extensible to other Plasmodium species
1 Trans. R. Soc. Trop. Med. Hyg. (2025) · doi:10.1093/trstmh/traf070
Network Architecture
Swappable backbone (dinoV3/ResNet50/etc) · multiple instance learning · operates on raw cell images · no staining
